Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Financial Statements Details - Outstanding Securities Considered Anti-Dilutive (Details)

v3.23.2
Condensed Consolidated Financial Statements Details - Outstanding Securities Considered Anti-Dilutive (Details) - $ / shares
shares in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Antidilutive Securities Excluded From Computation Of Earnings Per Share        
Antidilutive securities excluded from computation of net loss per share (in shares) 6,728 5,898 6,643 5,822
Common Stock        
Antidilutive Securities Excluded From Computation Of Earnings Per Share        
Stock price (in dollars per share) $ 18.89   $ 18.89  
Convertible preferred stock        
Antidilutive Securities Excluded From Computation Of Earnings Per Share        
Antidilutive securities excluded from computation of net loss per share (in shares) 5,003 5,003 5,003 5,003
Common stock options        
Antidilutive Securities Excluded From Computation Of Earnings Per Share        
Antidilutive securities excluded from computation of net loss per share (in shares) 1,719 889 1,634 813
Warrants for common stock        
Antidilutive Securities Excluded From Computation Of Earnings Per Share        
Antidilutive securities excluded from computation of net loss per share (in shares) 6 6 6 6